share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DICICCO WENDY F

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DICICCO WENDY F

EyePoint Pharmaceuticals | 4：持股變動聲明-董事 DICICCO WENDY F
美股SEC公告 ·  08/22 04:36
牛牛AI助理已提取核心訊息
Wendy F. DiCicco, associated with EyePoint Pharmaceuticals, Inc., completed a purchase of 2,567 shares of common stock on August 20, 2024. The transaction was carried out in the open market at a price of $7.79 per share. Following this acquisition, DiCicco's direct holdings in the company increased to a total of 9,967 shares of common stock.
Wendy F. DiCicco, associated with EyePoint Pharmaceuticals, Inc., completed a purchase of 2,567 shares of common stock on August 20, 2024. The transaction was carried out in the open market at a price of $7.79 per share. Following this acquisition, DiCicco's direct holdings in the company increased to a total of 9,967 shares of common stock.
Wendy F. DiCicco，與EyePoint Pharmaceuticals，Inc.有關，於2024年8月20日購買了2,567股普通股。該交易是在開放市場上以每股7.79美元的價格進行的。在此次收購之後，DiCicco在該公司的直接持有股份增加到總共9,967股普通股。
Wendy F. DiCicco，與EyePoint Pharmaceuticals，Inc.有關，於2024年8月20日購買了2,567股普通股。該交易是在開放市場上以每股7.79美元的價格進行的。在此次收購之後，DiCicco在該公司的直接持有股份增加到總共9,967股普通股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間